FIGHT KIDS CANCER is pleased to announce its next call for proposals, opening September 1st, dedicated to clinical and translational research in paediatric cancer.

Despite significant advances in oncology, many paediatric cancers have seen limited to no meaningful improvement in treatments over the past 40 years. To address these critical unmet needs, the FIGHT KIDS CANCER Programme Committee has decided to dedicate the 2026–2027 Call to research projects across all areas of paediatric cancer.

FIGHT KIDS CANCER aims to catalyse and support pan-European leading-edge research initiatives in paediatric cancer to develop innovative approaches to improve the outcome for all children and adolescents with cancer. This call will cover the following non-exclusive objectives:

• realise real impact on young patients
• improve survival rates and reduce toxicity to restore young patients to full health after treatment
• advance fundamental knowledge of paediatric malignancies
• support improved interdisciplinary research, methods and collaborations for tackling the issues of today
• strengthen collaboration and the development of scientific capacity across Europe

FIGHT KIDS CANCER aims towards overcoming the structural lack of research dedicated to paediatric cancers by ensuring a recurring endowment that will be granted to the best European research projects every year. An additional ambition is to foster closer working ties between clinical and laboratory researchers.

PRACTICAL INFORMATION

The funding amount and grant duration for each application will be as follows (see guidelines for applicants for further details):

Clinical Trials:

• Maximum funding: €5 000 000
• Maximum duration: 5 years

Clinical Trial Preparation Grants:

• Maximum funding: €250 000
• Maximum duration: 2 years (non-extendable, non-renewable)

Translational Research Projects:

• Maximum funding: €2 000 000
• Maximum duration: 4 years

The call, evaluation and selection process follow the structure and the provisional timeline below: